4.7 Article

Molecular Diagnosis of Respiratory Tract Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease

期刊

CLINICAL INFECTIOUS DISEASES
卷 52, 期 -, 页码 S290-S295

出版社

OXFORD UNIV PRESS INC
DOI: 10.1093/cid/cir044

关键词

-

资金

  1. Food and Drug Administration
  2. Infectious Diseases Society of America
  3. AstraZeneca Pharmaceuticals
  4. Bio Merieux, Inc.
  5. Cepheid
  6. Gilead Sciences
  7. Intelligent MDX, Inc.
  8. Inverness Medical Innovations
  9. Roche Molecular Systems

向作者/读者索取更多资源

Acute exacerbations are significant events in the course of chronic obstructive pulmonary disease. Modern diagnostic techniques have revealed an infectious cause for the majority of exacerbations. Common respiratory viruses contribute to 25%-50% of exacerbations. Detection of viral nucleic acids in nasopharyngeal swab or sputum samples has become the preferred method to study viral exacerbations instead of viral cultures and serologic examination. Clinical application of such molecular detection requires additional studies to clarify interpretation of a positive result. Bacteria account for 25%-50% of exacerbations. Studies comparing molecular detection of bacteria in sputum with conventional culture techniques have shown that a substantial proportion of bacteria are not detected by the latter method. However, as with molecular viral detection, clinical application of molecular bacterial diagnosis requires additional studies. Although still faced with several challenges and requiring additional development, it is quite likely that molecular methods will become the preferred methods for determining the etiology of exacerbations of chronic obstructive pulmonary disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据